What it is (overview)

A TORCH panel is a group of blood tests used to screen for infections that can be passed from a pregnant person to a developing baby (called congenital infections) or that can cause complications in pregnancy and early infancy. TORCH is an acronym that traditionally includes:

• Toxoplasmosis
• Other infections (commonly screened examples include syphilis; sometimes other pathogens may be considered based on history and local guidelines)
• Rubella
• Cytomegalovirus (CMV)
• Herpes simplex virus (HSV)

Most TORCH testing is done by measuring your immune system’s response to these infections—specifically antibodies in the blood:

• IgM antibodies: often suggest a recent or current infection (but can sometimes be falsely positive or persist longer than expected).
• IgG antibodies: usually indicate past exposure or immunity (for example, immunity after rubella vaccination).

In plain language, TORCH panel results generally mean:

• Negative/Not detected: no evidence of antibodies (or no evidence of recent infection, depending on which antibodies were tested). This may mean you have not been exposed, or it may be too early in infection to detect antibodies.
• IgG positive, IgM negative: suggests past infection or immunity; for rubella this often means protection from prior vaccination or prior infection.
• IgM positive (with or without IgG): may indicate a recent infection and may require confirmatory testing (repeat antibody testing, IgG avidity, or specific PCR tests) to clarify timing and risk.

Because each organism behaves differently, TORCH testing is best interpreted alongside symptoms, pregnancy timing, ultrasound findings, and any follow-up tests your clinician orders. In many regions, a “TORCH panel” is not a single standardized test everywhere—labs may include different infections or antibody types—so it’s helpful to review which components were included in your specific order.

When & why it's usually done

TORCH panel (or targeted TORCH components) is most often ordered for pregnancy testing or evaluation of possible congenital infection risk. Your clinician may recommend it when:

During pregnancy or preconception

• You have symptoms suggesting infection, such as fever, swollen lymph nodes, fatigue, rash, flu-like illness, or mouth/genital sores.
• You have a known exposure (e.g., close contact with someone with rubella, a partner with HSV, or potential exposure to syphilis).
• Ultrasound findings raise concern for congenital infection (for example, growth restriction, certain brain findings, fluid accumulation, or other abnormalities depending on the pathogen).
• You have risk factors for toxoplasmosis, such as eating undercooked meat, handling cat litter, or gardening without gloves (exposure to contaminated soil).
• You are unsure of rubella immunity, especially if vaccination history is unknown.

In newborns/infants

• A baby has signs that could suggest congenital infection, such as jaundice, hepatosplenomegaly, microcephaly, seizures, petechiae/purpura, hearing concerns, or eye problems.
• There is a maternal infection during pregnancy and the care team wants to assess potential impact on infant health.

Why it matters

These infections can be mild—or even unnoticed—in adults, but may carry higher risk during pregnancy or early life. Detecting a recent infection can help guide next steps, such as confirmatory tests (e.g., CMV or toxoplasma PCR), pregnancy monitoring, treatment decisions for infections like syphilis, and planning newborn evaluation and follow-up (including hearing and vision checks).

Common diseases related to it

• Toxoplasmosis (including congenital toxoplasmosis)
• Rubella (including congenital rubella syndrome)
• Cytomegalovirus (CMV) infection (including congenital CMV)
• Herpes simplex virus (HSV-1/HSV-2) infection (including neonatal herpes)
• Syphilis (including congenital syphilis)
• Congenital infections causing pregnancy complications (e.g., growth restriction, preterm birth, fetal anomalies) and newborn complications (e.g., hearing loss, vision problems)

Health goals where it may help

• Pregnancy planning and prenatal risk assessment (understanding immunity and exposure risks)
• Reducing the risk of congenital infections through early detection and appropriate follow-up
• Protecting infant health by guiding newborn screening, hearing/vision monitoring, and timely interventions
• Targeted infection evaluation when symptoms suggest toxoplasmosis, rubella, CMV, HSV, or syphilis
• Supporting immune system and virus screening decisions in high-risk exposures or concerning pregnancy ultrasound findings